Clinical Trial Update: Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing olanzapine to an aprepitant-based antiemetic regimen for highly emetogenic chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperemesis

Drugs mentioned

• aprepitant-based antiemetic regimen (aprepitant-based regimen)
• olanzapine (olanzapine)

Snippet

Sponsor: Mahidol University | Conditions: Antiemetic for Highly Emetogenic Chemotherapy | Phase 3 | Status: UNKNOWN